|
|
||||||||
1 Neuroendocrine Unit, 2 Department of Radiology, 3 Physical Therapy, and 4 General Clinical Research Center, Massachusetts General Hospital and Harvard Medical School, and 5 Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital and Harvard Medical School, Boston, Massachusetts 02114
Loss of lean body and muscle mass
characterizes the acquired immunodeficiency syndrome (AIDS) wasting
syndrome (AWS). Testosterone and exercise increase muscle mass in men
with AWS, with unclear effects on muscle composition. We examined
muscle composition in 54 eugonadal men with AWS who were randomized to
1) testosterone (200 mg im weekly) or placebo and
simultaneously to 2) resistance training or no training in a
2 × 2 factorial design. At baseline and after 12 wk, we performed
assessments of whole body composition by dual-energy X-ray
absorptiometry and single-slice computed tomography for midthigh
cross-sectional area and muscle composition. Leaner muscle has greater
attenuation. Baseline muscle attenuation correlated inversely with
whole body fat mass (r =
0.52, P = 0.0001). This relationship persisted in a model including age, body
mass index, testosterone level, viral load, lean body mass, and thigh
muscle cross-sectional area (P = 0.02). Testosterone (P = 0.03) and training (P = 0.03)
increased muscle attenuation. These data demonstrate that thigh muscle
attenuation by computed tomography varies inversely with whole body fat
and increases with testosterone and training. Anabolic therapy in these
patients increases muscle leanness.
resistance exercise training; muscle attenuation; acquired immunodeficiency syndrome
This article has been cited by other articles:
![]() |
J. Lo, L. E. Bernstein, B. Canavan, M. Torriani, M. B. Jackson, R. S. Ahima, and S. K. Grinspoon Effects of TNF-{alpha} neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E102 - E109. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Solomon and P M G Bouloux Modifying muscle mass - the endocrine perspective. J. Endocrinol., November 1, 2006; 191(2): 349 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Axell, H. E. MacLean, D. R. Plant, L. J. Harcourt, J. A. Davis, M. Jimenez, D. J. Handelsman, G. S. Lynch, and J. D. Zajac Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E506 - E516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Dolan, W. Frontera, J. Librizzi, K. Ljungquist, S. Juan, R. Dorman, M. E. Cole, J. R. Kanter, and S. Grinspoon Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med, June 12, 2006; 166(11): 1225 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Woodhouse, N. Gupta, M. Bhasin, A. B. Singh, R. Ross, J. Phillips, and S. Bhasin Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |